Background: Osteosarcoma is a rare disease, yet it is the most frequent primary malignant bone tumor, with poor survival in metastatic cases. Current PD-1 and PD-L1 checkpoint inhibitors show limited ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback